Office-Based Buprenorphine Treatment of Opioid Disorder

As the epidemic of opioid misuse and overdose deaths grows in the United States, practical information on evidence-based treatment of opioid use disorder (OUD) becomes increasingly important. This second edition of Office-Based Buprenorphine Treatment of Opioid Use Disorder offers just that: accessible and applicable guidance for anyone interested in learning more about prescribing buprenorphine. Bulleted clinical pearls at the end of each chapter, as well as specific clinical recommendations and detailed case discussions throughout the book, make it easier for readers to retain knowledge and integrate it into their practice. The guide also features sample documentation and scales, including a treatment contract and a patient consent, that can be used to model documents in practice. Among the updates in this new edition are chapters that address other pharmacotherapies useful in treating OUD, including methadone and naltrexone, as well as OUD treatment in the context of womens health and pregnancy. As an added bonus, this edition can also be used to complete the 8 hours of qualifying training required for the buprenorphine waiver. By a thorough reading of the material covered in the chapters of this book and successful completion of the posttest, physicians can meet the buprenorphine waiver training requirement.

John A. Renner Jr., M.D., is Professor of Psychiatry at Boston University School of Medicine and Associate Chief of Psychiatry of the VA Boston Healthcare System in Boston, Massachusetts.

Petros Levounis, M.D., M.A., is Professor and Chair of the Department of Psychiatry at Rutgers New Jersey Medical School and Chief of Service at University Hospital in Newark, New Jersey.

Anna T. LaRose, M.D., is Instructor in Psychiatry at Boston University Medical School and Staff Psychiatrist at the VA Boston Healthcare System in Boston, Massachusetts.